Biogen Inc.
做多

$BIIB - long, wait for better entry close to $280, target $300+

89
BIIB - long, better entry at $280, earnings soon 1/30, 1st target mid line of parallel channel around $300

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。